top of page
Contact us
Request an
appointment to
see a Key
Account Manager
3 steps to Dzuveo®
sublingual sufentanil tablets
02
Sign up for our emails to receive the latest news about Dzuveo®, including updates on new clinical data, support tools and product availability.
Safe administration
Dzuveo is to be administered by a healthcare professional in a medically monitored setting only. A medically monitored setting must have equipment and personnel trained to detect and manage hypoventilation, and availability of supplemental oxygen and opioid antagonists, such as naloxone. Dzuveo should only be prescribed and administered by healthcare professionals who are experienced in the management of opioid therapy; particularly opioid adverse reactions, such as respiratory depression
bottom of page